Development and evaluation of therapeutically relevant predictive classifiers using gene expression profiling

被引：52

作者：

Simon, Richard ^{[1
]}

机构：

[1] NCI, Biometr Res Branch, Div Canc Treatment & Diag, Bethesda, MD 20892 USA

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2006年 / 98卷 / 17期

关键词：

D O I：

10.1093/jnci/djj364

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1169 / 1171

页数：3

共 16 条

[1]

Asgharzadeh S, 2006, JNCI-J NATL CANCER I, V98, P1193, DOI 10.1093/jnci/djj330

[2] Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer [J].

Buyse, Marc ;

Loi, Sherene ;

van't Veer, Laura ;

Viale, Giuseppe ;

Delorenzi, Mauro ;

Glas, Annuska M. ;

d'Assignies, Mahasti Saghatchian ;

Bergh, Jonas ;

Lidereau, Rosette ;

Ellis, Paul ;

Harris, Adrian ;

Bogaerts, Jan ;

Therasse, Patrick ;

Floore, Arno ;

Amakrane, Mohamed ;

Piette, Fanny ;

Rutgers, Emiel ;

Sotiriou, Christos ;

Cardoso, Fatima ;

Piccart, Martine J. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (17) :1183-1192

[3]

FAN C, 2006, IN PRESS NEW ENGL J

[4] Adaptive signature design: An adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients [J].

Freidlin, B ;

Simon, R .

CLINICAL CANCER RESEARCH, 2005, 11 (21) :7872-7878

[5] Judging new markers by their ability to improve predictive accuracy [J].

Kattan, MW .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (09) :634-635

[6]

LUSA L, 2006, IN PRESS STAT MED

[7] Prediction error estimation: a comparison of resampling methods [J].

Molinaro, AM ;

Simon, R ;

Pfeiffer, RM .

BIOINFORMATICS, 2005, 21 (15) :3301-3307

[8] A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer [J].

Paik, S ;

Shak, S ;

Tang, G ;

Kim, C ;

Baker, J ;

Cronin, M ;

Baehner, FL ;

Walker, MG ;

Watson, D ;

Park, T ;

Hiller, W ;

Fisher, ER ;

Wickerham, DL ;

Bryant, J ;

Wolmark, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2817-2826

[9] Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker [J].

Pepe, MS ;

Janes, H ;

Longton, G ;

Leisenring, W ;

Newcomb, P .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (09) :882-890

[10] Roadmap for developing and validating therapeutically relevant genomic classifiers [J].

Simon, R .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (29) :7332-7341

← 1 2 →